Riluzole and blood pressure in multiple system atrophy
β Scribed by A. Lipp; J. Tank; M. Stoffels; G. Arnold; F. C. Luft; J. Jordan
- Publisher
- Springer
- Year
- 2003
- Tongue
- English
- Weight
- 207 KB
- Volume
- 13
- Category
- Article
- ISSN
- 0959-9851
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract We here report survival in patients with multiple system atrophy (MSA) in a large, prospectively studied group of patients with MSA. Eightyβfive of 100 patients were known to have died. Three patients were rediagnosed as having PD. Twentyβfour patients came to autopsy, which showed MSA
Lynch and Sima [I] point out that glial cytoplasmic inclusions (GCIs
Patients with multiple system atrophy (MSA) have a mean survival of 8 to 10 years. Nocturnal stridor has been considered a poor prognostic feature. We analyzed demographic, clinical, and polysomnographic data and obtained follow-up information from 42 patients with MSA (30 with follow-up data) seen